Principal Investigator
Izidore Lossos
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221182
Clinical Trial Summary
Study M22-716: A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647